Home
    Disclaimer
    πŸ§ͺ This is a research chemical with limited data on its long-term health effects, toxicity profile, and safe dosage ranges.

    25I-NBOH

    Aliases: Cimbi-27, Nboh-2c-i, nboh-2ci

    Summary TheDrug.Wiki TripSit PsychonautWiki

    25I-NBOH is approximately 2-3 times less potent than 25I-NBOMe but significantly more potent than 2C-I. Not orally active; must be administered sublingually or buccally. Extreme vasoconstriction and cardiovascular strain reported at higher doses.

    Perspectives

    “I can’t really see any permanent psychedelic therapy uses for this one, as while it does fill the user with beautiful colorful empathy while it lasts, it eventually fades to the exact same state as before. I can say though, it had the most beautiful and intense visuals of any trip.”

    Dose Information TheDrug.Wiki TripSit PsychonautWiki

    ROA Light Common Strong Heavy
    Sublingual 200-500Β΅g 500-900Β΅g 900-1400Β΅g 1400Β΅g+
    Buccal 200-500Β΅g 500-900Β΅g 900-1400Β΅g 1400Β΅g+
    Oral 416ug-766 800-1400Β΅g 1400ug-2000 2000Β΅g+
    Light Common Strong Heavy

    Onset, Duration & After-effects TheDrug.Wiki TripSit PsychonautWiki

    ROA Onset Comeup Peak Offset After Effects Total
    Sublingual 15-60 min 30-90 min 2-3.5 hrs 1.5-2.5 hrs 3-12 hrs 5-10 hrs
    Buccal 15-60 min 30-90 min 2-3.5 hrs 1.5-2.5 hrs 3-12 hrs 4.2-8.5 hrs
    Oral 19-45 min 30-90 min 2-3.5 hrs 1.5-2.5 hrs 3-12 hrs 5-10 hrs

    Effect Profile

    12 reports

    Scores (1–10) curated from multiple sources:

    • Effect keyword matching from PsychonautWiki catalog
    • Weighted by importance: core (×3), major (×2), minor (×1)

    Full methodology

    Psychedelic 8.4
    Intense 8/10

    Strong visuals, auditory effects, body load, and headspace

    Visual Intensity ×3
    10
    colour enhancement drifting tracers synaesthesia pattern recognition enhancement scenery slicing +6 more
    Headspace Depth ×3
    9
    conceptual thinking recursion emotion enhancement personal bias suppression time distortion confusion
    Auditory Effects ×1
    10
    auditory distortion auditory hallucination synaesthesia
    Body Load / Somatic Effects ×1
    10
    nausea temperature regulation suppression vasoconstriction muscle tension increased heart rate
    Stimulant 4.4
    Moderate 4/10

    Strong anxiety/jitters with moderate euphoria, mild stimulation and focus

    Stimulation / Energy ×3
    5
    stimulation wakefulness
    Euphoria / Mood Lift ×2
    6
    physical euphoria euphoria
    Focus / Productivity ×2
    4
    analysis enhancement thought acceleration
    Anxiety / Jitters ×1
    10
    anxiety restlessness paranoia increased heart rate vasoconstriction muscle tension

    Tolerance

    Build-up develops rapidly after a single use (serotonergic psychedelic)
    Reset 7–14 days for baseline

    Tolerance Decay

    Full tolerance 0h Half tolerance 7d Baseline ~14d

    Rapid within-session tolerance typical of serotonergic psychedelics; redosing adds side effects with limited benefit. Return to baseline generally reported within 1–3 weeks.

    Effects Erowid

    Aggregated from 12 Erowid experience reports

    Positive Effects 10

    Color Enhancement 75.0% 70%
    Tactile Enhancement 58.3% 70%
    Music Enhancement 58.3% 70%
    Introspection 50.0% 70%
    Stimulation 50.0% 70%
    Euphoria 41.7% 70%
    Empathy 41.7% 70%
    Focus Enhancement 33.3% 70%
    Pain Relief 33.3% 70%
    Body High 33.3% 70%

    Adverse Effects 5

    Nausea 50.0% 70%
    Muscle Tension 50.0% 70%
    Anxiety 41.7% 70%
    Confusion 33.3% 70%
    Pupil Dilation 25.0% 70%

    Combinations TripSit

    Trip Reports Effect Index

    Helpful Links